Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Covidien jumps into the high blood pressure arena with CE Mark in hand through $230M Maya merger
Covidien vaults into the renal denervation devices market with the acquisition of Maya Medical in a deal worth up to $230 million, gaining the OneShot system which already holds CE Mark approval and is set to begin a post-CE Mark clinical trial.
2. House panel speeds FDA user fee bill
A health subcommittee of the U.S. House of Representatives OKs a bill reauthorizing the FDA’s user fee program for the medical device and pharmaceutical industries.
1. GPO to IRS: Don’t let device companies raise prices to offset the device tax
Group purchasing organization Premier urges the IRS to certify that medical device makers aren’t passing on the burden of the impending 2.3% medical device levy by raising prices for their products.
